These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23585078)

  • 1. Lack of definitive evidence for the use of renin-angiotensin system antagonists for heart failure with preserved ejection fraction.
    Khalid U; Deswal A
    Evid Based Med; 2013 Dec; 18(6):226-7. PubMed ID: 23585078
    [No Abstract]   [Full Text] [Related]  

  • 2. Renin-Angiotensin system antagonists and mortality in patients with heart failure.
    Fonarow GC; Ahmed A
    JAMA; 2013 Mar; 309(11):1107. PubMed ID: 23512045
    [No Abstract]   [Full Text] [Related]  

  • 3. Renin-Angiotensin system antagonists and mortality in patients with heart failure--reply.
    Lund LH; Benson L
    JAMA; 2013 Mar; 309(11):1107-8. PubMed ID: 23512046
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M
    JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin-aldosterone system inhibitors in heart failure.
    Shearer F; Lang CC; Struthers AD
    Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure therapy: what should clinicians believe?
    Fang JC
    JAMA; 2012 Nov; 308(20):2144-6. PubMed ID: 23188032
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of renin-angiotensin system inhibitors on mortality in heart failure with preserved ejection fraction: a meta-analysis of observational cohort and randomized controlled studies.
    Fukuta H; Goto T; Wakami K; Ohte N
    Heart Fail Rev; 2017 Nov; 22(6):775-782. PubMed ID: 28702858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the renin-angiotensin-aldosterone system in heart failure.
    George J; Struthers AD; Lang CC
    Curr Atheroscler Rep; 2014 Apr; 16(4):403. PubMed ID: 24510580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin-aldosterone system inhibition in heart failure with mid-ranged ejection fraction: A systematic review and meta-analysis.
    Memon MM; Yamani N; Asmi N; Agrawal R; Khan MS
    Eur J Prev Cardiol; 2020 Dec; 27(19):2371-2373. PubMed ID: 30966823
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel blockers of the renin-angiotensin-aldosterone system in chronic heart failure.
    Valluri A; Struthers AD; Lang CC
    Curr Heart Fail Rep; 2014 Mar; 11(1):31-9. PubMed ID: 24234398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are angiotensin-converting enzyme inhibitors or angiotensin 2 receptor antagonists effective in heart failure with preserved ejection fraction?
    Rain C; Rada G
    Medwave; 2015 Mar; 15(2):e6101. PubMed ID: 25831411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5).
    Leong DP; McMurray JJV; Joseph PG; Yusuf S
    J Am Coll Cardiol; 2019 Aug; 74(5):683-698. PubMed ID: 31370961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foundations of Pharmacotherapy for Heart Failure With Reduced Ejection Fraction: Evidence Meets Practice, Part I.
    Paul S; Page RL
    J Cardiovasc Nurs; 2016; 31(2):101-13. PubMed ID: 26296245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-Angiotensin System Fingerprints of Heart Failure With Reduced Ejection Fraction.
    Pavo N; Wurm R; Goliasch G; Novak JF; Strunk G; Gyöngyösi M; Poglitsch M; Säemann MD; Hülsmann M
    J Am Coll Cardiol; 2016 Dec; 68(25):2912-2914. PubMed ID: 28007153
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of renin-angiotensin-aldosterone system in heart failure, or from CONSENSUS to PARADIGM-HF].
    Vítovec J; Špinar J; Špinarová L
    Vnitr Lek; 2015 May; 61(5):470-4. PubMed ID: 26075858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of RAAS inhibitors for the treatment of heart failure].
    Murohara T
    Nihon Rinsho; 2012 Sep; 70(9):1577-81. PubMed ID: 23012806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novelties in Therapy of Chronic Heart Failure.
    Doimo S; Pavan D
    Heart Fail Clin; 2021 Apr; 17(2):255-262. PubMed ID: 33673949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.
    Xie W; Zheng F; Song X; Zhong B; Yan L
    Int J Cardiol; 2016 Feb; 205():65-71. PubMed ID: 26720043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study.
    Edner M; Benson L; Dahlström U; Lund LH
    Eur Heart J; 2015 Sep; 36(34):2318-26. PubMed ID: 26069212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G; Bhat G
    Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.